In the first earnings report since merging with fellow Canadian cannabis producer Aphria, Tilray’s (TLRY) FQ4 results resonated well with investors. Shares surged by 26% in the subsequent session, even though the company’s sales failed to meet the analysts’ target. Tilray delivered revenue of $142.2 million, a 25.3% year-over-year increase, yet $88.1 million shy of the consensus estimate. Nevertheless, investors chose to focus on the positives and Benchmark’s Mike Hickey highlights the company’s “strengthening profitability metrics.” These include $12 million in Adjusted EBITDA, $8 million net cash from operating activities, and $3 million positive free cash flow, which compares well with the $28.
https://www.tipranks.com/news/article/is-tilray-stock-a-buy-right-now-this-is-what-you-need-to-know?utm_source=advfn.com&utm_medium=referral
Tilray (NASDAQ:TLRY)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Tilray Charts.
Tilray (NASDAQ:TLRY)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Tilray Charts.